Clinical trials for Acquired generalized lipodystrophy
6 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07220785Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized LipodystrophyRegeneron Pharmaceuticals · PI: Clinical Trial Management
- RECRUITINGPhase 3NCT06502990Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised LipodystrophyAmryt Pharma
- ACTIVE NOT RECRUITINGPhase 3NCT06548100A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)Regeneron Pharmaceuticals · PI: Clinical Trial Management
- ACTIVE NOT RECRUITINGN/ANCT03936829Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 DiabetesChildren's Hospital of Fudan University · PI: Feihong Luo
- RECRUITINGNCT03553420Registry for Patients With LipodystrophyUniversity of Ulm · PI: Martin Wabitsch, Prof. Dr.
- ACTIVE NOT RECRUITINGPhase 3NCT02262832Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · PI: Rebecca J Brown, M.D.